Ligand validation:3ZOK

GLY: GLYCINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZOK_GLY_C_1383	74%	34%	0.141	0.973	1.18	1.51	1	-	0	0	100%	1
3ZOK_GLY_B_1385	72%	28%	0.148	0.973	1.18	1.82	1	2	1	0	100%	1
3ZOK_GLY_A_1384	63%	30%	0.174	0.972	0.97	1.95	-	2	0	0	100%	1
3ZOK_GLY_D_1386	54%	26%	0.128	0.891	1.19	1.95	1	2	0	0	100%	1
3ZOK_GLY_D_1387	22%	38%	0.226	0.845	1.11	1.38	-	-	0	0	100%	1
4YKJ_GLY_A_302	99%	36%	0.06	0.995	1.1	1.49	1	-	1	0	100%	0.24
5I57_GLY_A_1001	98%	36%	0.058	0.984	0.83	1.75	-	2	1	0	100%	1
3KGR_GLY_B_801	98%	29%	0.063	0.986	1.29	1.65	1	1	0	0	100%	1
4OSY_GLY_A_402	98%	38%	0.067	0.986	1.06	1.42	-	-	1	0	100%	1
4O0F_GLY_A_404	97%	25%	0.064	0.981	1.36	1.81	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.